...
首页> 外文期刊>The Canadian journal of hospital pharmacy. >Tigecycline Treatment of Urinary Tract Infection and Prostatitis: Case Report and Literature Review
【24h】

Tigecycline Treatment of Urinary Tract Infection and Prostatitis: Case Report and Literature Review

机译:替加环素治疗尿路感染和前列腺炎:病例报告和文献复习

获取原文
获取原文并翻译 | 示例
           

摘要

Tigecycline, the first glycycline antibiotic, has been available in Canada since 2007. A systematic review of 8 randomized controlled trials (with a total of 4651 patients)1 suggested that the clinical and microbiological outcomes of tigecycline monotherapy were similar to those of empiric antibiotic regimens in the treatment of complicated skin and skin structure infections, intra-abdominal infections, and community-acquired pneumonia and other infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant Enterococcus (VRE). However, the incidence of adverse events, particularly nausea, was significantly higher with tigecycline than with the comparators.
机译:Tigecycline是首个甘氨酸环素抗生素,自2007年以来已在加拿大上市。对8项随机对照试验(共4651例患者)进行了系统回顾1,表明替加环素单药的临床和微生物学结果与经验性抗生素方案相似。用于治疗由耐甲氧西林的金黄色葡萄球菌(MRSA)或耐万古霉素的肠球菌(VRE)引起的复杂的皮肤和皮肤结构感染,腹腔内感染以及社区获得性肺炎和其他感染。但是,替加环素的不良事件发生率,特别是恶心,明显高于对照组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号